Malvern adds new particle characterization system

Malvern Instruments has announced the purchase of the Archimedes particle characterization system from Affinity Biosensors after having had an exclusive distribution agreement outside of North America and a co-marketing agreement in North America for the past two years. The system, including the intellectual property associated with it, is now fully owned by Malvern. The Archimedes . . . Read more

FDA approves Flonase for over the counter sales

GlaxoSmithKline has announced that the FDA has approved its Flonase fluticasone propionate nasal spray for the treatment of allergic rhinitis for over-the-counter sale. The approval is for a 50 mcg spray, the same as the current prescription strength. According to GSK, Flonase Allergy Relief will be available over the counter in the US in early . . . Read more

Milestone Pharmaceuticals appoints Francis Plat as Chief Medical Officer

Canadian pharmaceutical company Milestone Pharmaceuticals, which is developing an intranasal short-acting calcium channel antagonist for the treatment of paroxysmal supraventricular tachycardia, has announced the appointment of Francis Plat as Chief Medical Officer. Dr. Plat commented, “I am highly enthused to join Milestone in its development of MSP-2017, a promising product candidate, to alleviate acute episodes . . . Read more